MPG.eBooks - Search Results

Cover Image

1

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

2

Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

5

Pharmacoeconomic review report: Nusinersen (Spinraza) (Biogen Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

Pharmacoeconomic review report: Dolutegravir (Tivicay)

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

8

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2017

CADTH

Cover Image

10

Pharmacoeconomic review report: Sarilumab (Kevzara)

Published 2017

CADTH

Cover Image

11

CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

12

Pharmacoeconomic review report: Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

Pharmacoeconomic review report: Lumacaftor/Ivacaftor (Orkambi) (Vertex pharmaceuticals (Canada) Incorporated) : indication, for the treatment of cystic fibrosis in patients 6 years...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

14

Eltrombopag for the treatment of aplastic anemia : a review of clinical and cost-effectiveness

by Ho, Chuong, Visintini, Sarah
Published 2018

CADTH

Cover Image

15

Rituximab maintenance therapy for the management of granulomatosis with polyangiitis or microscopic polyangiitis : a review of clinical effectiveness, cost-effectiveness, and guide...

by Ho, Chuong, Adcock, Lorna
Published 2018

CADTH

Cover Image

16

Radioembolization with yttrium-90 microspheres for the management of uveal melanoma liver metastases : a review of clinical effectiveness and cost-effectiveness

by Ho, Chuong, McCormack, Suzanne
Published 2018

CADTH

Cover Image

17

Sensory rooms for patients with dementia in long-term care : clinical and cost-effectiveness, and guidelines

by Banerjee, Srabani, Ford, Caitlyn
Published 2018

CADTH

Cover Image

18

Biologics dose escalation for the treatment of inflammatory bowel disease : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Chao, Yi-Sheng, Visintini, Sarah
Published 2018

CADTH

Cover Image

19

Magnetic resonance imaging for prostate assessment : a review of clinical and cost-effectiveness

by Chiu, Stephanie, Adcock, Lorna
Published 2018

CADTH

Cover Image

20

Bowel preparation for elective colorectal procedures : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Khangura, Sara, La Fleur, Philip, Argáez, Charlene, Adcock, Lorna
Published 2018

CADTH

1
2
3
4
5
6
7
8
9
10
11